The ethanolic extract of Corylus avellana L. drives a microRNA-based cytotoxic effect on HepG2 hepatocarcinoma cells.
Maria PierdomenicoLoretta BacchettaBarbara BenassiPublished in: Natural product research (2023)
An ethanolic extract of Corylus avellana L. hazelnut was characterised by liquid chromatography coupled to high resolution mass spectrometry. We here evaluated the in vitro cytotoxic response to such extract in HepG2 cells and tried to depict the underlying mechanism(s) in terms of microRNA-34b/c involvement. Following long-term exposure (144h) of HepG2 cells with 0.04-0.4 mg/ml of hazelnut extract, we demonstrated that miR-34 precursor RNA and both mature miR-34b and miR-34c molecules underwent a significant stimulation (>2-fold change, p < 0.05) in cells treated with the highest concentration. The epigenetic modulation was accompanied by the inhibition of cell proliferation, the decrease of viability and activation of apoptosis at 144h of treatment with 0.4 mg/ml of hazelnut.These in vitro findings demonstrate the cytotoxic effect of the C. avellana extract in HepG2 cells and open the way to in vivo validation of possible application of hazelnut-based extracts, and/or its metabolites, as promising epigenetics drugs.
Keyphrases
- cell proliferation
- oxidative stress
- induced apoptosis
- cell cycle arrest
- liquid chromatography
- high resolution mass spectrometry
- long non coding rna
- anti inflammatory
- mass spectrometry
- pi k akt
- cell death
- endoplasmic reticulum stress
- long noncoding rna
- cell cycle
- tandem mass spectrometry
- minimally invasive
- signaling pathway
- high resolution
- combination therapy